Assessment of Knowledge Regarding Risks and Benefits of the Use of Non-Vitamin K Antagonist Oral Anticoagulants
CONCLUSIONS: There is an opportunity to improve NOAC-related knowledge in patients with atrial fibrillation. When developing educational interventions, patient characteristics associated with poor knowledge should be considered. Based on our results, these are patients who are older, more medically complex, are on apixaban, and have been on NOAC therapy for a shorter duration.PMID:36000450 | DOI:10.1177/21501319221118806
Source: Primary Care - Category: Primary Care Authors: Jose Raul Valery Ahmad Marar George Pujalte Cynthia Ward Yousif M Abdelmoneim Patrick J Fitzgerald Edson Mwakyanjala Dana M Harris Loren Murray Michael G Heckman Launia J White Fernando Stancampiano Source Type: research
More News: Atrial Fibrillation | Education | Laboratory Medicine | Primary Care | Stroke | Universities & Medical Training | Vitamin K | Vitamins